Sign Up Send Feedback Tell a Friend Search Archive View Sample
Weekly E-Mail newsletter
For physicians in Internal Medicine, Cardiology, Geriatrics, Women's Health,
and Adolescent Medicine
News from hundreds of top industry sources
It's what clinicians need to know
It's FREE!
  About SmartBrief

About The American Journal of Medicine, published by Elsevier

About Elsevier

Visit other Elsevier Health Science publications

Privacy Policy
Send AJMPlus story to a colleague.

* Your Name
* Your E-mail
* Friend's E-mail
Separate multiple addresses with commas.
  Personal Message
* Indicates required fields
Terms and Conditions: You must submit valid e-mail addresses only. Use of e-mail addresses is subject to the terms of SmartBrief's privacy policy.
Here's the story you're sending:
The obesity paradox and aortic valve implantation
Obesity was associated with a higher incidence of minor but no major perioperative complications after transcatheter aortic valve implantation (TAVI). After TAVI adjustment, obesity was found to be associated with a lower risk of 30-day mortality and had no adverse effect on mortality after discharge, underscoring the ?obesity paradox? in patients undergoing TAVI.  The American Journal of Cardiology (1/15)